167 related articles for article (PubMed ID: 21782124)
1. Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas.
Le-Petross H; Lane D
Semin Ultrasound CT MR; 2011 Aug; 32(4):342-50. PubMed ID: 21782124
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic carcinoma of the breast.
Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
[TBL] [Abstract][Full Text] [Related]
3. Unusual malignant tumors of the breast: MRI features and pathologic correlation.
Linda A; Zuiani C; Girometti R; Londero V; Machin P; Brondani G; Bazzocchi M
Eur J Radiol; 2010 Aug; 75(2):178-84. PubMed ID: 19446418
[TBL] [Abstract][Full Text] [Related]
4. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
[TBL] [Abstract][Full Text] [Related]
5. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
Varga Z; Mallon E
Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.
Intra M; Rotmensz N; Viale G; Mariani L; Bonanni B; Mastropasqua MG; Galimberti V; Gennari R; Veronesi P; Colleoni M; Tousimis E; Galli A; Goldhirsch A; Veronesi U
Cancer; 2004 Sep; 101(5):905-12. PubMed ID: 15329896
[TBL] [Abstract][Full Text] [Related]
7. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
10. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Rosa M; Mohammadi A; Masood S
Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
[TBL] [Abstract][Full Text] [Related]
13. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations and histological type of invasive breast carcinoma.
Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
[TBL] [Abstract][Full Text] [Related]
15. Incidental finding of mammary carcinoma in lumpectomy specimens.
Tang P; Hajdu SI; Conte CC; Filardi DA
Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
[TBL] [Abstract][Full Text] [Related]
16. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
18. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
19. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
20. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]